Pope Leo XIV’s Brother Louis Prevost Faces Cancer Relapse
Matthew Rabinowitz: I Can Think of No One Better to Lead Natera into Its Next Chapter
Radiotherapy Vs Observation in Grade 2 Meningioma
Does Red 40 Cause Cancer? Food Dye Safety and Cancer Risk Explained
HERON-Lung01: Ruzaltatug Rezetecan Reduces Progression Risk in EGFR-Mutated NSCLC Following EGFR-TKI Therapy
SIOG Announces Kwok-Leung Cheung as President and Introduces 2026–2028 Board of Directors
Nelli Bejanyan at LeukO 2026: Beyond CAR-T in the Fight Against AML Relapse After Transplantation
Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
